NLRP3 and pulmonary arterial hypertension: To this end we hypothesize that complement activation could provoke NLRP3 inflammasome cascade, subsequently induces proinflammatory cytokines (IL-1β and IL-18), and could further promote endothelial dysfunction and vascular remodeling in pulmonary arterioles, finally results in PAH.